Engineered to maintain reliability in process-driven workflows, the HPLC column NUCLEODUR® C 8 Gravity, featuring a 3 μm particle size and a 125 mm length, is designed to deliver optimal performance in reversed-phase separations. Its high-density C 8 phase, based on high-purity NUCLEODUR® silica gel, offers superior base deactivation (BDS) and pH stability ranging from 1 to 11, making it an ideal choice for method development and RP applications. Furthermore, this analytical separation column's endcapping suppresses unwanted polar interactions, ensuring its suitability for the separation of basic and other ionizable analytes, including pharmaceuticals, antidepressants, and herbicides.

• Category: Separation columns for HPLC
• Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
• Specific surface according to BET: 340 m²/g
• Pore volume: 0.9 ml/g
• Eluent in column: Acetonitrile - Water
• pH stability: 1,0-11,0
• Pressure stability: 600 bar
• L x Ø internal (column): 125 x 4.6 mm
• Surface chemistry: Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification
• Column volume: 2.06 ml
• Column shape: Analytical separation column
• Phase: C 8 Gravity
• Separation principle: Reversed phase (RP)
• Interactions / retention mechanism: hydrophobic (van der Waals)
• Particle size: 3 µm
• Temperature stability: 60 ° C
• Similar phases: NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8
• Endcapped: yes
• USP listing: L7
• Column type: HPLC column
• Particle type: Fully porous particles (FPP)
• Pore size: 110 Å